Marcia Cruz-Correa
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Marcia Cruz-Correa
Jun 18, 2024, 07:07 |
Insight
Tislelizumab plus chemotherapy in advanced gastric/GEJ adenocarcinoma
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X: "Tislelizumab plus chemotherapy vs…
May 21, 2024, 11:18 |
Blog
Marcia Cruz-Correa: Celebrating USCongressNews the 2024 AACR Cancer Disparities Progress Report
Marcia Cruz-Correa, Chief Medical Officer at PanOncology Trials, shared a post on LinkedIn: "Celebrating US…
May 21, 2024, 10:50 |
Blog
CRCHD's Director Sanya A. Springfield participated in the release of the AACR's 2024 Cancer Disparities Progress Report - National Cancer Institute
National Cancer Institute shared a post on LinkedIn: "NCI Center to Reduce Cancer Health Disparities…
Jan 28, 2024, 13:07 |
Opinion
Olalekan Ajayi: Exciting Insights from Hospital Oncologico, San Juan, Puerto Rico
Olalekan Ajayi, Chief Operating Officer of Highlands Oncology Group and President of Association of Community Cancer…
All:
4
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube